Nissim Darvish is a veteran of the lifescience industry, with over 15 years of experience covering medical technology development, corporate leadership and investment management.Nissim is currently Senior Managing Director at OrbiMed Israel, the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.
Prior to his current position, Nissim spent eight years with Pitango, where he was a General Partner managing life sciences investments. Previously, Nissim was the founder and CEO of Impulse Dynamics, which he led for six years, culminating in a $250 million realization event.
Nissim obtained his MD and PhD in Biophysics and Physiology from the Technion in Israel, and subsequently conducted his postdoctoral research at the NIH.
He has published over 100 patents, authored over 20 publications, and received eight prizes and awards. Nissim has served on the boards of multiple companies, including Inotek Pharmaceuticals Inc., SuperDimension, Vascular Biogenics, and Inca Medical.